ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
8
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
4,522
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Effect of comedications on paritaprevir, ritonavir, ombitasvir, dasabuvir and ribavirin pharmacokinetics [abstract no. 52]
Author(s):
AR Polepally
,
P Badri
,
EP Coakley
,
Mihir A. Parikh
,
L Rodrigues
,
B. Tillmann
Publication date:
2015
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Dermal Microdialysis in Pharmacokinetics
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
4,522
Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir + Ribavirin (3D + RBV) Treatment of Hepatitis C (HCV) Genotype 1 (GT1) Infected Patients (pts) after Failure to Previous First Generation Protease-Inhibitor (PI) Therapy Interim Analysis
Authors:
F Szalay
,
M. Schneider
,
F. Schneider
…
HCV cirrhosis at the edge of decompensation: Will paritaprevir with ritonavir, ombitasvir, dasabuvir, and ribavirin solve the need for treatment?
Authors:
Tarik Asselah
,
Savino Bruno
,
Antonio Craxì
501 Comparative Effectiveness of Ledipasvir/Sofosbuvir±Ribavirin and Ombitasvir/Paritaprevir/Ritonavir+Dasabuvir±Ribavirin in 6,961 Genotype 1 Patients Treated in Routine Medical Practice
Authors:
Lisa I. Backus
,
Pamela Belperio
,
Troy Shahoumian
…
See all similar
Cited by
1
Drug–Drug Interactions Between the Anti-Hepatitis C Virus 3D Regimen of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and Eight Commonly Used Medications in Healthy Volunteers
Authors:
Akshanth Polepally
,
Jennifer R. King
,
Bifeng Ding
…
See all cited by